| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 02/18/2004 | EP0734264B1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/2004 | CN1476326A Treatment of PCP addiction and PCP addiction-related behavior |
| 02/17/2004 | US6692724 Composition comprising ethylenedicysteine conjugated with tissue specific ligand which is anticancer agent, glutamate pentapeptide, or folate receptor, tumor apoptotic cell or tumor hypoxia cell targeting ligand, and radionuclide label |
| 02/17/2004 | US6692426 Sterile radioactive seeds |
| 02/17/2004 | CA2145505C Microparticle preparations made from biodegradable copolymers |
| 02/12/2004 | WO2004013285A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | WO2004013180A2 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
| 02/12/2004 | WO2004012776A1 Isotopically labelled indolinone derivatives and process for their preparation |
| 02/12/2004 | WO2003024976A3 Tricyclic indole derivatives as 5-ht ligands |
| 02/12/2004 | WO2002074346A3 Targeting chemical compounds to cells |
| 02/12/2004 | WO2002059609A3 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 02/12/2004 | WO2002053700A3 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 02/12/2004 | WO2002052046A3 Oligonucleotide transfection screening method |
| 02/12/2004 | US20040030248 Intraductal management of breast lesions involving therapeutic or diagnostic agents |
| 02/12/2004 | US20040029963 Use of pamoic acid or one of its derivatives, or one of its analogues , for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates |
| 02/12/2004 | US20040029182 For diagnosis/therapy of colorectal cancer |
| 02/12/2004 | US20040028609 Two-dimensionally quantified image method for distinguishing and quantifying over-growing tissue or the like |
| 02/12/2004 | US20040028607 Polypeptides; antiproliferative agent |
| 02/12/2004 | US20040028606 Novel radiotherapeutic formulations containing 224ra and a method for their production |
| 02/12/2004 | US20040028573 Device for synthesis of radiopharmaceutical products |
| 02/12/2004 | CA2494607A1 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | CA2494310A1 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
| 02/11/2004 | EP1388013A2 Compositions and methods for the use of fibronectin fragments in the diagnosis of cancer |
| 02/11/2004 | EP1387701A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy |
| 02/11/2004 | EP1083937B1 Radioioinated phenols for brachytherapy |
| 02/11/2004 | EP0804482B1 Cytokines that bind the cell surface receptor hek |
| 02/11/2004 | CN1137732C Detection of H. pylori in stomach |
| 02/10/2004 | US6689338 Bioconjugates of nanoparticles as radiopharmaceuticals |
| 02/10/2004 | US6689337 Vitronectin receptor antagonist pharmaceuticals |
| 02/10/2004 | CA2214247C Modulators of amyloid aggregation |
| 02/08/2004 | CA2433114A1 Method of using metaloporphyrins for treatment of arteriosclerotic lesions |
| 02/05/2004 | WO2004011426A2 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| 02/05/2004 | WO2004011010A1 Myocardial perfusion imaging using a2a receptor agonists |
| 02/05/2004 | WO2004010951A2 Method of treating tumors |
| 02/05/2004 | WO2003037172A3 Endothelial-cell binding peptides for diagnosis and therapy |
| 02/05/2004 | US20040024307 Para-hydrogen labeled agents and their use in magnetic resonance imaging |
| 02/05/2004 | US20040024060 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/05/2004 | US20040024015 Enhancing chemotherapy/radition therapy; endothelial growth factors; side effects reduction |
| 02/05/2004 | US20040023912 Method of diagnosis and treatment of breast lesions |
| 02/05/2004 | US20040023299 Diagnosis of liver disease |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/05/2004 | US20040022737 Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 02/05/2004 | US20040022727 For therapy of proliferative diseases |
| 02/05/2004 | US20040022726 Administering via urethra multispecific antibody; allowing antibody to localize at the site of bladder cancer, allowing free antibody to clear from patient; administering carrier conjugated to one or more therapeutic agents |
| 02/05/2004 | US20040022725 Stable radioiodine conjugates and methods of their synthesis |
| 02/05/2004 | CA2494715A1 Method for automated, large-scale measurement of the molecular flux rates using mass spectrometry |
| 02/05/2004 | CA2493172A1 Method of treating tumors |
| 02/04/2004 | EP1386934A1 Diagnostic agents for pancreatic exocrine function |
| 02/04/2004 | EP1385556A1 Gastrin-receptor-avid peptide conjugates |
| 02/04/2004 | EP1385480A1 Liposomes |
| 02/04/2004 | EP1385476A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 02/04/2004 | EP0783326B1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 02/04/2004 | CN1473158A Radiopharmaceuticals for diagnosing alzheimer's disease |
| 02/04/2004 | CN1136921C Myocardial developer and its prepn. |
| 02/03/2004 | US6685943 Fibronectin binding protein compositions and methods of use |
| 02/03/2004 | US6685942 Passive immmunotherapy; fab fragment that neutralizes both antigenic subgroup a and subgroup b |
| 02/03/2004 | US6685914 Contrast agents in x-ray imaging, magnetic resonance imaging (mri) and radiopharmaceuticals, heavy metal detoxification; 1,4,8,11-tetraaza-6,13-phosphacyclotetradecane compound with phosphinic bridges |
| 02/03/2004 | US6685913 Lipid soluble radioactive metal chelates for tumor therapy |
| 02/03/2004 | US6685912 Post-labeling stabilization of radiolabeled proteins and peptides |
| 02/03/2004 | US6685618 Method for delivering radiation to an intraluminal site in the body |
| 01/29/2004 | WO2004009586A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 01/29/2004 | WO2004009136A2 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds |
| 01/29/2004 | WO2004009135A2 Conjugates of biocompatible polymers with nuclide activation therapy reagents |
| 01/29/2004 | WO2004009089A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 01/29/2004 | WO2003101948A3 Agents for imaging and diagnostic methods using them |
| 01/29/2004 | US20040018960 Antitumor agents; autoimmune diseases; antiarthritic agents; restenosis |
| 01/29/2004 | US20040018557 High speed elimination of immunoglobulins from human body |
| 01/29/2004 | US20040018198 Antibodies against carbonic anydrase IX (CA IX) tumor antigen |
| 01/29/2004 | US20040018189 Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancer |
| 01/29/2004 | US20040018148 Conjugating radioiodinated peptides or carbohydrate structures to proteins with improved yields and qualities of conjugates. In one method, specially designed radioiodinated bifunctional peptides containing nonmetabolizable amide bonds are coupled |
| 01/29/2004 | US20040018147 Active ingredient a technetium-99m nitride heterocomplex comprising technetium-99m nitride and two different ligands coordinated therewith, i.e., a bisphosphinoamine compound as a pi electron acceptor and a bidentate ligand as a pi electron |
| 01/29/2004 | CA2493252A1 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds |
| 01/29/2004 | CA2492878A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 01/28/2004 | EP1384488A2 Method and kit for imaging organs and tissues, using labelled antibodies |
| 01/28/2004 | EP1383922A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 01/28/2004 | EP1383802A2 Anti-muc-1 single chain antibodies for tumor targeting |
| 01/28/2004 | EP1383800A1 RECOMBINANT ANTIBODIES COEXPRESSED WITH GnTIII |
| 01/28/2004 | EP1383747A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 01/28/2004 | EP1383740A2 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors |
| 01/28/2004 | EP1383544A1 Anti-cd19 immunotoxins |
| 01/28/2004 | EP1383510A1 Bisphosphonate conjugates and methods of making and using the same |
| 01/28/2004 | EP0996471B1 Radionuclide microparticles bound to elastomeric hose for the endovascular therapy |
| 01/28/2004 | CN1471407A Multifunctional nano device platform |
| 01/28/2004 | CN1470290A Radioactive nano ferror nuclein medicine and its medical use |
| 01/28/2004 | CN1470288A Medical use of paramagnetic material |
| 01/27/2004 | US6683163 Monitoring angiogenesis factor |
| 01/27/2004 | US6683162 Especially an actinium isotope complex of 2-(p-isothiocyanatobenzyl)-1,4,7,10-tetraazocyclododecane-1,4,7,10 -tetraacetic acid that is covalently bonded to an antibody or fragment |
| 01/27/2004 | US6683105 Highly selective butyrylcholinesterase inhibitors such as cymserine or others can prevent or treat cognitive impairments associated with aging or alzheimer's disease |
| 01/27/2004 | US6683062 Attaching a bioeffecting agent to a substrate with an anchor provided by a linker compound which also forms a cleavable linkage so that the drug has a sustained release; anti-thrombogenic, -imicrobial, -inflammatory agents |
| 01/27/2004 | US6682906 Cloned glutamic acid decarboxylase |
| 01/27/2004 | US6682734 Anti-cd20 derived from transfectoma having atcc deposit numbers 69119 and hbe 1388 respectively; depletion of peripheral blood b cells |
| 01/27/2004 | US6682733 Fibrinolytic enzymes |
| 01/22/2004 | WO2004007557A2 Tf antagonist |
| 01/22/2004 | WO2004006860A2 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
| 01/22/2004 | WO2003074569A3 Bispecific antibody point mutations for enhancing rate of clearance |
| 01/22/2004 | US20040015075 Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures |
| 01/22/2004 | US20040014964 Vitronectin receptor antagonist pharmaceuticals |
| 01/22/2004 | US20040013687 Complexing Clostridium botulinum; translocation; induction immunology response |
| 01/22/2004 | US20040013675 In situ detection of tumors; diagnosis of epilepsy, Alzheimer's disease, brain disorders |
| 01/22/2004 | CA2492475A1 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |